NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status
Read More
Author: John Pinching
MHRA grants marketing authorisation for Novartis’ Pluvicto
Radioligand therapy involves patients with advanced prostate cancer in Great Britain
Read More
Medicines Discovery Catapult and Zeiss join forces
Partnership will focus on driving the application of microscopy in drug discovery
Read More
Key blood clotting protein could be ‘warning light’ for COVID-19 cases
University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19
Read More
SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy
Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
